Rare diseases
Investigational molecules
Locations
BI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
PolandA study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis
PolandA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
PolandA study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis
PolandA study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis
PolandA study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis
PolandA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
PolandA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
PolandA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
PolandA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
